Tumor necrosis factor α in the pathogenesis of cerebral malaria

Cellular and Molecular Life Sciences

Volumn 60, Issue 8, 2003, Pages 1623-1635

  Gimenez, F ^a   De Lagerie, S Barraud ^a   Fernandez, C ^a   Pino, P ^b   Mazier, D ^b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b INSERM   (France)

Author keywords

Adhesion molecules; Blood brain barrier; Cerebral malaria; Cytokine; TNF receptor; Tumor necrosis factor

Indexed keywords

ANTIBODY; ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; LYMPHOTOXIN; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

BINDING AFFINITY; BLOOD BRAIN BARRIER; BRAIN DISEASE; BRAIN MALARIA; CENTRAL NERVOUS SYSTEM; CONSCIOUSNESS DISORDER; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; ERYTHROCYTE; IMMUNE SYSTEM; NEUROLOGY; PATHOGENESIS; PLASMODIUM FALCIPARUM; RECEPTOR BINDING; REVIEW; SEIZURE; UPREGULATION;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CELL ADHESION MOLECULES; DISEASE MODELS, ANIMAL; HUMANS; INTERLEUKIN-10; MALARIA, CEREBRAL; MICE; NITRIC OXIDE; POLYMORPHISM, GENETIC; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE; PLASMODIUM FALCIPARUM;

EID: 0042329758     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-003-2347-x     Document Type: Review

References (105)

1. Mazier D., Nitcheu J. and Idrissa-Boubou M. (2000) Cerebral malaria and immunogenetics. Parasite Immunol. 22: 613-623
2. Craig A. and Scherf A. (2001) Molecules on the surface of the Plasmodium falciparum infected erythrocyte and their role in malaria pathogenesis and immune evasion. Mol. Biochem. Parasitol. 115: 129-143
3. Meager A. (1999) Cytokine regulation of cellular adhesion molecule expression in inflammation. Cytokine Growth Factor Rev. 10: 27-39
4. + T Lymphocytes mediate experimental cerebral malaria pathogenesis. J. Immunol. 170: 2221-2228
5. Brown H., Turner G., Rogerson S., Tembo M., Mwenechanya J., Molyneux M. et al. (1999) Cytokine expression in the brain in human cerebral malaria. J. Infect. Dis. 180: 1742-1746
6. Bazzoni F. and Beutler B. (1996) The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 334: 1717-1725
7. Munoz-Fernandez M. A. and Fresno M. (1998) The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog. Neurobiol. 56: 307-340
8. Wallach D. (1996) A decade of accumulated knowledge and emerging answers. The 6th international congress on TNF Rhodes, Greece. May 1996. Eur. Cytokine. Netw. 7: 713-724
9. Kwiatkowski D., Molyneux M. E., Stephens S., Curtis N., Klein N., Pointaire P. et al. (1993) Anti-TNT therapy inhibits fever in cerebral malaria. Q. J. Med. 86: 91-98
10. May J., Lell B., Luty A. J., Meyer C. G. and Kremsner P. G. (2000) Plasma interleukin-10: Tumor necrosis factor (TNF)-alpha ratio is associated with TNF promoter variants and predicts malarial complications. J. Infect. Dis. 182: 1570-1573
11. Tessier P. A., Naccache P. H., Clark-Lewis I., Gladue R. P., Neote K. S. and McColl S. R. (1997) Chemokine networks in vivo: involvement of C-X-C and C-C chemokines in neutrophil extravasation in vivo in response to TNF-alpha. J. Immunol. 159: 3595-3602
12. Ringwald P., Peyron F., Lepers J. P., Rabarison P., Rakotomalala C., Razanamparany M. et al. (1993) Parasite virulence factors during falciparum malaria: rosetting, cytoadherence and modulation of cytoadherence by cytokines. Infect. Immun. 61: 5198-5204
13. Gnant M. F., Turner E. M. and Alexander H. R., Jr. (2000) Effects of hyperthermia and tumour necrosis factor on inflammatory cytokine secretion and procoagulant activity in endothelial cells. Cytokine 12: 339-347
14. Grell M., Zimmermann G., Gottfried E., Chen C. M., Grunwald U., Huang D. C. et al. (1999) Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. EMBO J. 18: 3034-3043
15. Mehler M. F. and Kessler J. A. (1997) Hematolymphopoietic and inflammatory cytokines in neural development. Trends Neurosci. 20: 357-365
16. Marino M. W., Dunn A., Grail D., Inglese M., Noguchi Y., Richards E. et al. (1997) Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94: 8093-8098
17. Akassoglou K., Probert L., Kontogeorgos G. and Kollias G. (1997) Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J. Immunol. 158: 438-445
18. Lee Y. B., Schrader J. W. and Kim S. U. (2000) p38 map kinase regulates TNF-alpha production in human astrocytes and microglia by multiple mechanisms. Cytokine 12: 874-880
19. Probert L., Akassoglou K., Pasparakis M., Kontogeorgos G and Kollias G. (1995) Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc. Natl. Acad. Sci. USA 92: 11294-11298
20. Beeson J. G and Brown G. V. (2002) Pathogenesis of Plasmodium falciparum malaria: the roles of parasite adhesion and antigenic variation. Cell. Mol. Life Sci. 59: 258-271
21. Richards A. L. (1997) Tumour necrosis factor and associated cytokines in the host's response to malaria. Int. J. Parasitol. 27: 1251-1263
22. Nussler A., Drapier J. C., Renia L., Pied S., Miltgen F., Gentilini M. et al. (1991) L-arginine-dependent destruction of intrahepatic malaria parasites in response to tumor necrosis factor and/or interleukin 6 stimulation. Eur. J. Immunol. 21: 227-230
23. Nussler A., Pied S., Goma J., Renia L., Miltgen F., Grau G. E. et al. (1991) TNF inhibits malaria hepatic stages in vitro via synthesis of IL-6. Int. Immunol. 3: 317-321.
24. Schofield L., Vivas L., Hackett F., Gerold P., Schwarz R. T. and Tachado S. (1993) Neutralizing monoclonal antibodies to glycosylphosphatidylinositol, the dominant TNF-alpha-inducing toxin of Plasmodium falciparum: prospects for the immunotherapy of severe malaria. Ann. Trop. Med. Parasitol. 87: 617-626
25. Schofield L., Novakovic S., Gerold P., Schwarz R. T., McConville M. J. and Tachado S. D. (1996) Glycosylphosphatidylinositol toxin of Plasmodium up-regulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction. J. Immunol. 156: 1886-1896
26. Tachado S. D., Gerold P., McConville M. J., Baldwin T., Quilici D., Schwarz R. T. et al. (1996) Glycosylphosphatidytinositol toxin of Plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelial cells by a protein tyrosine kinase-dependent and protein kinase C-dependent signaling pathway. J. Immunol. 156: 1897-1907
27. Schofield L., Hewitt M., Evans K., Siomos M. and Seeberger P. (2002) Synthetic GPI as a candidate antitoxic vaccine in a model of malaria. Nature 418: 785-789
28. Naotunne T. S., Karunaweera N. D., Del Giudice G., Kularatne M. U., Grau G. E., Carter R. et al. (1991) Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential. J. Exp. Med. 173: 523-529
29. Yoeli M. (1976) Chadwick lecture. Cerebral malaria - the quest for suitable experimental models in parasitic diseases of man. Trans. R. Soc. Trop. Med. Hyg. 70: 24-35
30. Kwiatkowski D., Cannon J. G., Manogue K. R., Cerami A., Dinarello C. A. and Greenwood B. M. (1989). Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture. Clin. Exp. Immunol. 77: 361-366
31. Wahlgren M., Carlson J., Helmby H., Hedlund I. and Treutiger C. J. (1992) Molecular mechanisms and biological importance of Plasmodium falciparum erythrocyte rosetting. Mem. Inst. Oswaldo Cruz 87: 323-329
32. Kawai S., Aikawa M., Kano S. and Suzuki M. (1993) A primate model for severe human malaria with cerebral involvement: Plasmodium coatneyi-infected Macaca fuscata. Am. J. Trop. Med. Hyg. 48: 630-636
33. Hearn J., Rayment N., Landon D. N., Katz D. R. and de Souza J. B. (2000) Immunopathology of cerebral malaria: morphological evidence of parasite sequestration in murine brain microvasculature. Infect. Immun. 68: 5364-5376
34. Lou J., Lucas R. and Grau G.E. (2001) Pathogenesis of cerebral malaria: recent experimental data and possible application for humans. Clin. Microbiol. Rev. 14: 810-820
35. Akanmori B. D., Kurtzhals J. A., Goka B. Q., Adabayeri V., Ofori M. F., Nkrumah F. K. et al. (2000) Distinct patterns of cytokine regulation in discrete clinical forms of Plasmodium falciparum malaria. Eur. Cytokine. Netw. 11: 113-118
36. Shaffer N., Grau G. E., Hedberg K., Davachi F., Lyamba B., Hightower A. W. et al. (1991) Tumor necrosis factor and severe malaria. J. Infect. Dis. 163: 96-101
37. Grau G. E., Heremans H., Piguet P. F., Pointaire P., Lambert P. H., Billiau A. et al. (1989) Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc. Natl. Acad. Sci. USA 86: 5572-5574
38. Kern P., Hemmer C. J., Van Damme J., Gruss H. J. and Dietrich M. (1989) Elevated tumor necrosis factor alpha and interleukin-6 sennn levels as markers for complicated Plasmodium falciparum malaria. Am. J. Med. 87: 139-143
39. Kwiatkowski D., Hill A. V., Sambou I., Twumasi P., Castracane J., Manogue K. R. et al. (1990) TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336: 1201-1204
40. Karunaweera N. D., Grau G. E., Gamage P., Carter R. and Mendis K. N. (1992) Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc. Natl. Acad. Sci. USA 89: 3200-3203
41. Day N. P., Hien T. T., Schollaardt T., Loc P. P., Chuong L. V., Chau T. T. et al. (1999) The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J. Infect. Dis. 180: 1288-1297
42. Grau G. E., Piguet P. F., Vassalli P. and Lambert P. H. (1989) Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data. Immunol. Rev. 112: 49-70
43. Newton C. R. and Krishna S. (1998) Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol. Ther. 79: 1-53
44. Hill A. V., Allsopp C. E., Kwiatkowski D., Anstey N. M., Twumasi P., Rowe P. A. et al. (1991) Common west African HLA antigens are associated with protection from severe malaria. Nature 352: 595-600
45. Wilson A. G., Symons J. A., McDowell T. L., McDevitt H. O., and Duff G. W. (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. USA 94: 3195-3199
46. McGuire W., Knight J. C., Hill A. V., Allsopp C. E., Greenwood B. M. and Kwiatkowski D. (1999) Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J. Infect. Dis. 179: 287-290
47. McGuire W., Hill A. V., Allsopp C. E., Greenwood B. M. and Kwiatkowski D. (1994) Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371: 508-510
48. Aidoo M., McElroy P. D., Kolczak M. S., Terlouw D. J., ter Kuile F. O., Nahlen B. et al. (2001) Tumor necrosis factor-alpha promoter variant 2 (TNF2) is associated with pre-term delivery, infant mortality and malaria morbidity in western Kenya: Asembo Bay Cohort Project IX. Genet. Epidemiol. 21: 201-211
49. Knight J. C., Udalova I., Hill A. V., Greenwood B. M., Peshu N., Marsh K. et al. (1999) A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat. Genet. 22: 145-150
50. Ubalee R., Suzuki F., Kikuchi M., Tasanor O., Wattanagoon Y., Ruangweerayut R. et al. (2001) Strong association of a tumor necrosis factor-alpha promoter allele with cerebral malaria in Myanmar. Tissue Antigens 58: 407-410
51. Allan R. J., Beattie P., Bate C., Van Hensbroek M. B., Morris-Jones S., Greenwood B. M. et al. (1995) Strain vanation in tumor necrosis factor induction by parasites from children with acute falciparum malaria. Infect. Immun. 63: 1173-1175
52. Grau G. E., Fajardo L. F., Piguet P. F., Allet B., Lambert P. H. and Vassalli P. (1987) Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 237: 1210-1212
53. Grau G. E. and Lou J. (1993) TNF in vascular pathology: the importance of platelet-endothelium interactions. Res. Immunol. 144: 355-363
54. Clark I. A., Ilschner S., MacMicking J. D. and Cowden W. B. (1990) TNF and Plasmodium berghei ANKA-induced cerebral malaria. Immunol. Lett. 25: 195-198
55. de Kossodo S. and Grau G. E. (1993) Profiles of cytokine production in relation with susceptibility to cerebral malaria. J. Immunol. 151: 4811-4820
56. Jennings V. M., Actor J. K., Lal A. A. and Hunter R. L. (1997) Cytokine profile suggesting that murine cerebral malaria is an encephalitis. Infect Immun 65: 4883-4887
57. Rudin W., Eugster H. P., Bordmann G., Bonato J., Muller M., Yamage M. et al. (1997) Resistance to cerebral malaria in tumor necrosis factor-alpha/beta-deficient mice is associated with a reduction of intercellular adhesion molecule-1 up-regulation and T helper type 1 response. Am. J. Pathol. 150: 257-266
58. Amani V., Vigario A. M., Belnoue E., Marussig M., Fonseca L., Mazier D. et al. (2000) Involvement of IFN-γ receptor-mediated signalling in protection against Plasmodium berghei infection and its pathology. Eur. J. Immunol. 30: 1646-1655
59. Yanez D. M., Manning D. D., Cooley A. J., Weidanz W. P. and van der Heyde H. C. (1996) Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J. Immunol. 157: 1620-1624
60. Engwerda C. R., Mynott T. L., Sawhney S., De Souza J. B., Bickle Q. D. and Kaye P. M. (2002) Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J. Exp. Med. 195: 1371-1377
61. Dietrich J. B. (2002) The adhesion molecule ICAM-1 and its regulation in relation with the blood-brain barrier. J. Neuroimmunol. 128: 58-68
62. Baud V. and Karin M. (2001) Signal transduction by tumor necrosis factor and its relatives. Trends Cell. Biol. 11: 372-377
63. Brown H., Hien T. T., Day N., Mai N. T., Chuong L. V., Chau T. T. et al. (1999) Evidence of blood-brain barrier dysfunction in human cerebral malana. Neuropathol. Appl. Neurobiol. 25: 331-340
64. Prudhomme J. G., Sherman I. W., Land K. M., Moses A. V., Stenglein S. and Nelson J. A. (1996) Studies of Plasmodium falciparum cytoadherence using immortalized human brain capillary endothelial cells. Int. J. Parasitol. 26: 647-655
65. Dobbie M. S., Hurst R. D., Klein N. J. and Surtees R. A. (1999) Upregulation of intercellular adhesion molecule-1 expression on human endothelial cells by tumour necrosis factor-alpha in an in vitro model of the blood-brain barrier. Brain Res. 830: 330-336
66. Lou J., Gasche Y., Zheng L., Critico B., Monso-Hinard C., Juillard P. et al. (1998) Differential reactivity of brain microvascular endothelial cells to TNF reflects the genetic susceptibility to cerebral malaria. Eur. J. Immunol. 28: 3989-4000
67. McGuire W., Hill A. V., Greenwood B. M. and Kwiatkowski D. (1996) Circulating ICAM-1 levels in falciparum malaria are high but unrelated to disease severity. Trans. R. Soc. Trop. Med. Hyg. 90: 274-276
68. Favre N., Da Laperousaz C., Ryffel B., Weiss N. A., Imhof B. A., Rudin W. et al. (1999) Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect. 1: 961-968
69. Mayhan W. G. (2002) Cellular mechanisms by which tumor necrosis factor-alpha produces disruption of the blood-brain barrier. Brain Res. 927: 144-152
70. Descamps L., Cecchelli R. and Torpier G (1997) Effects of tumor necrosis factor on receptor-mediated endocytosis and barrier functions of bovine brain capillary endothelial cell monolayers. J. Neuroimmunol. 74: 173-184
71. Petito C. K., Adkins B., Tracey K., Roberts B., Torres-Munoz J., McCarthy M. et al. (1999) Chronic systemic administration of tumor necrosis factor alpha and HIV gp120: effects on adult rodent brain and blood-brain barrier. J. Neurovirol. 5: 314-318
72. Schnell L., Fearn S., Schwab M. E., Perry V. H. and Anthony D. C. (1999) Cytokine-induced acute inflammation in the brain and spinal cord. J. Neuropathol. Exp. Neurol. 58: 245-254
73. de Vries H.E., Blom-Roosemalen M.C., van Oosten M., de Boer A.G., van Berkel T.J., Breimer D.D. et al. (1996) The influence of cytokines on the integrity of the blood-brain barrier in vitro. J. Neuroimmunol. 64: 37-43
74. Mark K.S. and Miller D.W. (1999) Increased permeability of primary cultured brain microvessel endothelial cell monolayers following TNF-alpha exposure. Life Sci. 64: 1941-1953
75. Dickstein J. B., Moldofsky H., Lue F. A. and Hay J. B. (1999) Intracerebroventricular injection of TNF-alpha promotes sleep and is recovered in cervical lymph. Am. J. Physiol. 276: R1018-1022
76. Tsao N., Hsu H. P. and Lei H. Y. (1999) TNFalpha-induced cyclooxygenase 2 not only increases the vasopermeability of blood-brain barrier but also enhances the neutrophil survival in Escherichia coli-induced brain inflammation. Prostaglandins Other Lipid Mediat. 57: 371-382
77. Saija A., Princi P., Lanza M., Scalese M., Aramnejad E. and De Sarro A. (1995) Systemic cytokine administration can affect blood-brain barrier permeability in the rat. Life Sci. 56: 775-784
78. Migasena P. and Maegraith B. G. (1968) Factor affecting on the movement of protein across the blood: brain: C.S.F. barriers in Plasmodium knowlesi infected Macaca mulatta. Med. J. Malaya 22: 251
79. Pino P., Vouldoukis I., Mahmoudi M., Kolb J. P., Desportes-Livage I., Danis M. et al. (2002) Plasmodium falciparum-infected erythrocyte adhesion induces caspase activation and apoptosis in human endothelial cells. J. Infect. Dis., in press
80. Derouich-Guergour D., Brenier-Pinchart M. P., Ambroise-Thomas P. and Pelloux H. (2001) Tumour necrosis factor alpha receptors: role in the physiopathology of protozoan parasite infections. Int. J. Parasitol. 31: 763-769
81. Lucas R., Lou J. N., Juillard P., Moore M., Bluethmann H. and Grau G. E. (1997) Respective role of TNF receptors in the development of experimental cerebral malaria. J. Neuroimmunol. 72: 143-148
82. Piguet P.F., Kan C.D. and Vesin C. (2002) Role of the tumor necrosis factor receptor 2 (TNFR2) in cerebral malaria in mice. Lab. Investig. 82: 1155-1166
83. Lucas R., Lou J., Morel D. R., Ricou B., Suter P. M. and Grau G. E. (1997) TNF receptors in the microvascular pathology of acute respiratory distress syndrome and cerebral malaria. J. Leukoc. Biol. 61: 551-558
84. Sibson N. R., Blamire A. M., Perry V. H., Gauldie J., Styles P. and Anthony D. C. (2002) TNF-α reduces cerebral blood volume and disrupts tissue homeostasis via an endothelin- and TNFR2-dependent pathway. Brain 125: 2446-2459
85. Lesslauer W., Tabuchi H., Gentz R., Brockhaus M., Schlaeger E. J., Grau G. et al. (1991) Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality. Eur. J. Immunol. 21: 2883-2886
86. Garcia I., Miyazaki Y., Araki K., Araki M., Lucas R., Grau G.E. et al. (1995) Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections. Eur. J. Immunol. 25: 2401-2407
87. Clark I. A., Rockett K. A. and Cowden W. B. (1991) Role of TNF in cerebral malaria. Lancet 337: 302-303
88. Clark I. A., Rockett K. A. and Cowden W. B. (1992) Possible central role of nitric oxide in conditions clinically similar to cerebral malaria. Lancet 340: 894-896
89. Kremsner P. G., Neifer S., Rasenack T. and Bienzle U. (1993) Interference by antimalarial drugs with the in vitro production of reactive nitrogen intermediates by murine macrophages. J. Antimicrob. Chemother. 31: 385-392
90. Kremsner P. G., Nussler A., Neifer S., Chaves M. F., Bienzle U., Senaldi G. et al. (1993). Malaria antigen and cytokine-induced production of reactive nitrogen intermediates by murine macrophages: no relevance to the development of experimental cerebral malaria. Immunology 78: 286-290
91. Vouldoukis I., Pino P., Dugas N., Olivier R., Nitcheu J., Traore B. et al. (2002) Nitric oxide production by CD23-bearing human pulmonary endothelial cells down-regulates the expression of ICAM-1 and decreases cyto-adherence of Plasmodium falciparum infected erythrocytes. Molecular Medicine, in press
92. Ho M., Sexton M. M., Tongtawe P., Looareesuwan S., Suntharasamai P. and Webster H. K. (1995) Interleukin-10 inhibits, tumor necrosis factor production but not antigen-specific lymphoproliferation in acute Plasmodium falciparum malaria. J. Infect. Dis. 172: 838-844
93. Wenisch C., Parschalk B., Narzt E., Looareesuwan S. and Graninger W. (1995) Elevated serum levels of IL-10 and IFN-gamma in patients with acute Plasmodium falciparum malaria. Clin. Immunol. Immunopathol. 74: 115-117
94. Eckwalanga M., Marussig M., Tavares M. D., Bouanga J. C., Hulier E., Pavlovitch J. H. et al. (1994) Murine AIDS protects mice against experimental cerebral malaria: down- regulation by interleukin 10 of a T-helper type 1 CD4+ cell-mediated pathology. Proc. Natl. Acad. Sci. USA 91: 8097-8101
95. Kossodo S., Monso C., Juillard P., Velu T., Goldman M. and Grau G. E. (1997) Interleukin-10 modulates susceptibility in experimental cerebral malaria. Immunology 91: 536-540
96. Othoro C., Lal A. A., Nahlen B., Koech D., Orago A. S. and Udhayakumar V. (1999) A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. J. Infect. Dis. 179: 279-282
97. Kurtzhals J. A., Adabayeri V., Goka B. Q., Akanmori B. D., Oliver-Commey J. O., Nkrumah F. K. et al. (1998). Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet 351: 1768-1772
98. Curfs J. H., Hermsen C. C., Kremsner P., Neifer S., Meuwissen J. H., Van Rooyen N. et al. (1993) Tumour necrosis factor-alpha and macrophages in Plasmodium berghei-induced cerebral malaria. Parasitology 107 (Pt 2): 125-134
99. Postma N. S., Crommelin D. J., Eling W. M. and Zuidema J. (1999) Treatment with liposome-bound recombinant human tumor necrosis factor-alpha suppresses parasitemia and protects against Plasmodium berghei k173-induced experimental cerebral malaria in mice. J. Pharmacol. Exp. Ther. 288: 114-120
100. Curfs J. H., Hermsen C. C., Meuwissen J. H. and Eling W. M. (1992) Immunization against cerebral pathology in Plasmodium berghei-infected mice. Parasitology 105 (Pt 1): 7-14
101. van Hensbroek M. B., Palmer A., Onyiorah E., Schneider G., Jaffar S., Dolan G. et al. (1996) The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. J. Infect. Dis. 174: 1091-1097
102. Looareesuwan S., Sjostrom L., Krudsood S., Wilairatana P., Porter R. S., Hills F. et al. (1999) Polyclonal anti-tumor necrosis factor-alpha Fab used as an ancillary treatment for severe malaria. Am. J. Trop. Med. Hyg. 61: 26-33
103. Looareesuwan S., Wilairatana P., Vannaphan S., Wanaratana V., Wenisch C., Aikawa M. et al. (1998) Pentoxifylline as an ancillary treatment for severe falciparum malaria in Thailand. Am. J. Trop. Med. Hyg. 58: 348-353
104. Wenisch C., Looareesuwan S., Wilairatana P., Parschalk B., Vannapann S., Wanaratana V. et al. (1998) Effect of pentoxifylline on cytokine patterns in the therapy of complicated Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 58: 343-347
105. Hemmer C. J., Hort G., Chiwakata C. B., Seitz R., Egbring R., Gaus W. et al. (1997) Supportive pentoxifylline in falciparum malaria: no effect on tumor necrosis factor alpha levels or clinical outcome: a prospective, randomized, placebo-controlled study. Am. J. Trop. Med. Hyg. 56: 397-403